Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

BMC Musculoskeletal Disorders

Volumn 10, Issue , 2009, Pages

  Gülfe, Anders ^a   Aletaha, Daniel ^b   Saxne, Tore ^a   Geborek, Pierre ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR; C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE IN 28 JOINT; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; REMISSION; RHEUMATOID ARTHRITIS; SIMPLE DISEASE ACTIVITY INDEX; SWEDEN; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG ANTAGONISM; FOLLOW UP; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY;

ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; SWEDEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549149155     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-10-41     Document Type: Article

References (16)

1. Afdelning Reumatologie UMC Sint Radboud Nijmegen. http://www.das-score.nl
2. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. PJS Smolen, Rheumatology (Oxford) 2003 42 2 244 57 10.1093/rheumatology/keg072 12595618 (Pubitemid 36305610)
3. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. DNV Aletaha T Stamm M Uffmann S Pflugbeil K Machold JS Smolen, Arthritis Research & Therapy 2005 7 R796 R806 15987481 10.1186/ar1740
4. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. A Zink, Arthritis Rheum 2006 54 11 3399 407 10.1002/art.22193 17075823
5. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. Arthritis Rheum 2007 57 2 193 202 10.1002/art.22552 17330293 (Pubitemid 47164079)
6. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. AM van Gestel, Arthritis Rheum 1996 39 1 34 40 10.1002/art.1780390105 8546736 (Pubitemid 26036375)
7. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. DT Felson, Arthritis Rheum 1995 38 6 727 35 10.1002/art.1780380602 7779114
8. Response criteria for rheumatoid arthritis in clinical practice: how useful are they? A Gulfe P Geborek T Saxne, Ann Rheum Dis 2005 64 8 1186 9 15760931 10.1136/ard.2004.027649 (Pubitemid 41113354)
9. Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis. P Geborek T Saxne, Rheumatology (Oxford) 2000 39 10 1159 61 10.1093/rheumatology/39.10.1159 11035144
10. Understanding interobserver agreement: the kappa statistic. AJ Viera JM Garrett, Fam Med 2005 37 5 360 3 15883903 (Pubitemid 40656185)
11. The measurement of observer agreement for categorical data. JRKG Landis, Biometrics 1977 33 159 174 10.2307/2529310 843571 (Pubitemid 8054849)
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. KL Hyrich, Rheumatology (Oxford) 2006 45 12 1558 65 10.1093/rheumatology/kel149 16705046
13. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. LE Kristensen MC Kapetanovic A Gülfe M Söderlin T Saxne P Geborek, Rheumatology (Oxford) 2008 47 4 495 9 10.1093/rheumatology/ken002 18316338
14. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. D Aletha J S, Clin Exp Rheumatol 2005 23 5 Suppl 39 S100 S108 16273793 (Pubitemid 40216352)
15. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. D Aletaha, Arthritis Rheum 2005 52 9 2625 36 10.1002/art.21235 16142705 (Pubitemid 41369090)
16. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. F Wolfe, Arthritis Rheum 2007 57 6 935 42 10.1002/art.22895 17665487 (Pubitemid 47237319)